Browsing Tag
Nasdaq Stockholm
6 posts
Yubico expands C-suite with cybersecurity veterans — can this fuel the next phase of phishing-resistant security?
Yubico expands leadership team with new CFO, CPTO, and SVP to accelerate growth in global authentication. Learn what this means for investors.
Imlifidase clears pivotal US Phase 3 trial with strong kidney transplant results as Hansa Biopharma eyes FDA filing
Hansa Biopharma’s Imlifidase meets its Phase 3 trial endpoint in US kidney transplantation, setting up FDA filing and reshaping biotech investor sentiment.
Verisure’s €3.1bn IPO on Nasdaq Stockholm: Is Europe’s biggest security firm worth buying?
Verisure’s €3.1B Nasdaq Stockholm IPO signals a comeback to public markets. Find out why it matters for investors, Sweden, and Europe’s IPO revival.
Hexagon AB appoints Anders Svensson as President and CEO as it eyes autonomy, robotics, and AI-led growth
Anders Svensson takes over as Hexagon AB CEO, steering autonomy, AI, and spin-off plans. Find out what this means for growth and investor sentiment.
BioArctic advances exidavnemab phase 2a cohorts after safety review
BioArctic expands its Phase 2a trial for exidavnemab after a successful safety review. Read how this impacts Parkinson’s and MSA drug development today.
Aristocrat Leisure to refocus on core gaming with Plarium Global sale to Modern Times Group
Aristocrat Leisure Limited has announced a pivotal decision to sell its mobile gaming subsidiary, Plarium Global, to Modern…